Beta-blockers: once or three times a day?

In a double-blind, crossover trial 16 hypertensive patients were treated, in random order, with placebo, metoprolol 300 mg in a single daily dose, or metoprolol 300 mg/day in three doses. Both therapeutic regimens produced detectable plasma metoprolol concentrations and appreciable beta-blockade, es...

Full description

Saved in:
Bibliographic Details
Published in:BMJ 1978-05, Vol.1 (6124), p.1386-1388
Main Authors: Reybrouck, T, Amery, A, Fagard, R, Jousten, P, Lijnen, P, Meulepas, E
Format: Article
Language:English
Subjects:
Adult
Blood plasma
Blood pressure
Clinical Trials as Topic
Diastolic blood pressure
Dosage
Double-Blind Method
Drug Administration Schedule
Female
Heart Function Tests
Heart rate
Humans
Hypertension
Hypertension - drug therapy
Male
Medical treatment
Metoprolol - administration & dosage
Metoprolol - blood
Metoprolol - therapeutic use
Middle Aged
Physical Exertion
Placebos
Propanolamines - administration & dosage
Stress tests
Writing tablets
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b4256-d32feae2f0d9e2cd738e8b1c7ca59f17578c6f39649b5c2fe173e487010c3e693
cites
container_end_page 1388
container_issue 6124
container_start_page 1386
container_title BMJ
container_volume 1
creator Reybrouck, T
Amery, A
Fagard, R
Jousten, P
Lijnen, P
Meulepas, E
description In a double-blind, crossover trial 16 hypertensive patients were treated, in random order, with placebo, metoprolol 300 mg in a single daily dose, or metoprolol 300 mg/day in three doses. Both therapeutic regimens produced detectable plasma metoprolol concentrations and appreciable beta-blockade, estimated from exercise tachycardia, throughout the day. Fluctuations throughout the day in plasma drug concentrations and degree of beta-blockade were insignificant on the thrice-daily regimen, but they varied considerably on the single-dose regimen. Both therapeutic regimens also significantly lowered blood pressure throughout the day. Although the thrice-daily regimen again tended to produce a stronger and less fluctuating hypotensive action, the differences in hypotensive effect between the two regimens were not statistically significant. A single-dose of 300 mg of metoprolol can therefore be recommended if the only aim is to reduce blood pressure but not if a steady degree of beta-blockade is needed.
doi_str_mv 10.1136/bmj.1.6124.1386
format article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1604739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>20419162</jstor_id><sourcerecordid>20419162</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4256-d32feae2f0d9e2cd738e8b1c7ca59f17578c6f39649b5c2fe173e487010c3e693</originalsourceid><addsrcrecordid>eNqFkc1v1DAQxa0KWlalZy4gRUKqVKRsPbZjOxyoIOJLWuBSuFqOM6HZJnGxs4j-93WUalW4cLKs9_PMe36EPAO6BuDyvB62a1hLYGINXMsDsgIhdV5ozh-RFaVU5SCEekJOYtymK-NKl1IckUMuNJN0Rc7e4WTzuvfuGkN8nfnRYeZDNl0FxGzqBoyZzRp7e_GUPG5tH_Hk_jwm3z-8v6w-5ZtvHz9Xbzd5LVgh84azFi2yljYlMtcorlHX4JSzRdmCKpR2suXJRVkXLrGgOAqtKFDHUZb8mLxZ5t7s6gEbh-MUbG9uQjfYcGu87czfythdmZ_-twFJheLzgNP7AcH_2mGczNBFh31vR_S7aNS8PIVP4Mt_wK3fhTGFM6CU5FQXJUvU-UK54GMM2O6tADVzCya1YMDMLZi5hfTi-cMEe3758yS_WORtnHzYq4wKKEHOC_NF7-KEf_a6DddGKq4K8_VHZeiG8i-XVWXmda8WfvbxP2931cqmeA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776308592</pqid></control><display><type>article</type><title>Beta-blockers: once or three times a day?</title><source>PubMed (Medline)</source><source>BMJ Journals Online 英国医学会数据库</source><creator>Reybrouck, T ; Amery, A ; Fagard, R ; Jousten, P ; Lijnen, P ; Meulepas, E</creator><creatorcontrib>Reybrouck, T ; Amery, A ; Fagard, R ; Jousten, P ; Lijnen, P ; Meulepas, E</creatorcontrib><description>In a double-blind, crossover trial 16 hypertensive patients were treated, in random order, with placebo, metoprolol 300 mg in a single daily dose, or metoprolol 300 mg/day in three doses. Both therapeutic regimens produced detectable plasma metoprolol concentrations and appreciable beta-blockade, estimated from exercise tachycardia, throughout the day. Fluctuations throughout the day in plasma drug concentrations and degree of beta-blockade were insignificant on the thrice-daily regimen, but they varied considerably on the single-dose regimen. Both therapeutic regimens also significantly lowered blood pressure throughout the day. Although the thrice-daily regimen again tended to produce a stronger and less fluctuating hypotensive action, the differences in hypotensive effect between the two regimens were not statistically significant. A single-dose of 300 mg of metoprolol can therefore be recommended if the only aim is to reduce blood pressure but not if a steady degree of beta-blockade is needed.</description><identifier>ISSN: 0007-1447</identifier><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>DOI: 10.1136/bmj.1.6124.1386</identifier><identifier>PMID: 348260</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Adult ; Blood plasma ; Blood pressure ; Clinical Trials as Topic ; Diastolic blood pressure ; Dosage ; Double-Blind Method ; Drug Administration Schedule ; Female ; Heart Function Tests ; Heart rate ; Humans ; Hypertension ; Hypertension - drug therapy ; Male ; Medical treatment ; Metoprolol - administration &amp; dosage ; Metoprolol - blood ; Metoprolol - therapeutic use ; Middle Aged ; Physical Exertion ; Placebos ; Propanolamines - administration &amp; dosage ; Stress tests ; Writing tablets</subject><ispartof>BMJ, 1978-05, Vol.1 (6124), p.1386-1388</ispartof><rights>Copyright 1978 British Medical Journal</rights><rights>Copyright BMJ Publishing Group LTD May 27, 1978</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4256-d32feae2f0d9e2cd738e8b1c7ca59f17578c6f39649b5c2fe173e487010c3e693</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1604739/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1604739/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,3181,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/348260$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reybrouck, T</creatorcontrib><creatorcontrib>Amery, A</creatorcontrib><creatorcontrib>Fagard, R</creatorcontrib><creatorcontrib>Jousten, P</creatorcontrib><creatorcontrib>Lijnen, P</creatorcontrib><creatorcontrib>Meulepas, E</creatorcontrib><title>Beta-blockers: once or three times a day?</title><title>BMJ</title><addtitle>Br Med J</addtitle><description>In a double-blind, crossover trial 16 hypertensive patients were treated, in random order, with placebo, metoprolol 300 mg in a single daily dose, or metoprolol 300 mg/day in three doses. Both therapeutic regimens produced detectable plasma metoprolol concentrations and appreciable beta-blockade, estimated from exercise tachycardia, throughout the day. Fluctuations throughout the day in plasma drug concentrations and degree of beta-blockade were insignificant on the thrice-daily regimen, but they varied considerably on the single-dose regimen. Both therapeutic regimens also significantly lowered blood pressure throughout the day. Although the thrice-daily regimen again tended to produce a stronger and less fluctuating hypotensive action, the differences in hypotensive effect between the two regimens were not statistically significant. A single-dose of 300 mg of metoprolol can therefore be recommended if the only aim is to reduce blood pressure but not if a steady degree of beta-blockade is needed.</description><subject>Adult</subject><subject>Blood plasma</subject><subject>Blood pressure</subject><subject>Clinical Trials as Topic</subject><subject>Diastolic blood pressure</subject><subject>Dosage</subject><subject>Double-Blind Method</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Heart Function Tests</subject><subject>Heart rate</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - drug therapy</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Metoprolol - administration &amp; dosage</subject><subject>Metoprolol - blood</subject><subject>Metoprolol - therapeutic use</subject><subject>Middle Aged</subject><subject>Physical Exertion</subject><subject>Placebos</subject><subject>Propanolamines - administration &amp; dosage</subject><subject>Stress tests</subject><subject>Writing tablets</subject><issn>0007-1447</issn><issn>0959-8138</issn><issn>1468-5833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1978</creationdate><recordtype>article</recordtype><recordid>eNqFkc1v1DAQxa0KWlalZy4gRUKqVKRsPbZjOxyoIOJLWuBSuFqOM6HZJnGxs4j-93WUalW4cLKs9_PMe36EPAO6BuDyvB62a1hLYGINXMsDsgIhdV5ozh-RFaVU5SCEekJOYtymK-NKl1IckUMuNJN0Rc7e4WTzuvfuGkN8nfnRYeZDNl0FxGzqBoyZzRp7e_GUPG5tH_Hk_jwm3z-8v6w-5ZtvHz9Xbzd5LVgh84azFi2yljYlMtcorlHX4JSzRdmCKpR2suXJRVkXLrGgOAqtKFDHUZb8mLxZ5t7s6gEbh-MUbG9uQjfYcGu87czfythdmZ_-twFJheLzgNP7AcH_2mGczNBFh31vR_S7aNS8PIVP4Mt_wK3fhTGFM6CU5FQXJUvU-UK54GMM2O6tADVzCya1YMDMLZi5hfTi-cMEe3758yS_WORtnHzYq4wKKEHOC_NF7-KEf_a6DddGKq4K8_VHZeiG8i-XVWXmda8WfvbxP2931cqmeA</recordid><startdate>19780527</startdate><enddate>19780527</enddate><creator>Reybrouck, T</creator><creator>Amery, A</creator><creator>Fagard, R</creator><creator>Jousten, P</creator><creator>Lijnen, P</creator><creator>Meulepas, E</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19780527</creationdate><title>Beta-blockers: once or three times a day?</title><author>Reybrouck, T ; Amery, A ; Fagard, R ; Jousten, P ; Lijnen, P ; Meulepas, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4256-d32feae2f0d9e2cd738e8b1c7ca59f17578c6f39649b5c2fe173e487010c3e693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1978</creationdate><topic>Adult</topic><topic>Blood plasma</topic><topic>Blood pressure</topic><topic>Clinical Trials as Topic</topic><topic>Diastolic blood pressure</topic><topic>Dosage</topic><topic>Double-Blind Method</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Heart Function Tests</topic><topic>Heart rate</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - drug therapy</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Metoprolol - administration &amp; dosage</topic><topic>Metoprolol - blood</topic><topic>Metoprolol - therapeutic use</topic><topic>Middle Aged</topic><topic>Physical Exertion</topic><topic>Placebos</topic><topic>Propanolamines - administration &amp; dosage</topic><topic>Stress tests</topic><topic>Writing tablets</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reybrouck, T</creatorcontrib><creatorcontrib>Amery, A</creatorcontrib><creatorcontrib>Fagard, R</creatorcontrib><creatorcontrib>Jousten, P</creatorcontrib><creatorcontrib>Lijnen, P</creatorcontrib><creatorcontrib>Meulepas, E</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reybrouck, T</au><au>Amery, A</au><au>Fagard, R</au><au>Jousten, P</au><au>Lijnen, P</au><au>Meulepas, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beta-blockers: once or three times a day?</atitle><jtitle>BMJ</jtitle><addtitle>Br Med J</addtitle><date>1978-05-27</date><risdate>1978</risdate><volume>1</volume><issue>6124</issue><spage>1386</spage><epage>1388</epage><pages>1386-1388</pages><issn>0007-1447</issn><issn>0959-8138</issn><eissn>1468-5833</eissn><abstract>In a double-blind, crossover trial 16 hypertensive patients were treated, in random order, with placebo, metoprolol 300 mg in a single daily dose, or metoprolol 300 mg/day in three doses. Both therapeutic regimens produced detectable plasma metoprolol concentrations and appreciable beta-blockade, estimated from exercise tachycardia, throughout the day. Fluctuations throughout the day in plasma drug concentrations and degree of beta-blockade were insignificant on the thrice-daily regimen, but they varied considerably on the single-dose regimen. Both therapeutic regimens also significantly lowered blood pressure throughout the day. Although the thrice-daily regimen again tended to produce a stronger and less fluctuating hypotensive action, the differences in hypotensive effect between the two regimens were not statistically significant. A single-dose of 300 mg of metoprolol can therefore be recommended if the only aim is to reduce blood pressure but not if a steady degree of beta-blockade is needed.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>348260</pmid><doi>10.1136/bmj.1.6124.1386</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1447
ispartof BMJ, 1978-05, Vol.1 (6124), p.1386-1388
issn 0007-1447
0959-8138
1468-5833
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1604739
source PubMed (Medline); BMJ Journals Online 英国医学会数据库
subjects Adult
Blood plasma
Blood pressure
Clinical Trials as Topic
Diastolic blood pressure
Dosage
Double-Blind Method
Drug Administration Schedule
Female
Heart Function Tests
Heart rate
Humans
Hypertension
Hypertension - drug therapy
Male
Medical treatment
Metoprolol - administration & dosage
Metoprolol - blood
Metoprolol - therapeutic use
Middle Aged
Physical Exertion
Placebos
Propanolamines - administration & dosage
Stress tests
Writing tablets
title Beta-blockers: once or three times a day?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A41%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beta-blockers:%20once%20or%20three%20times%20a%20day?&rft.jtitle=BMJ&rft.au=Reybrouck,%20T&rft.date=1978-05-27&rft.volume=1&rft.issue=6124&rft.spage=1386&rft.epage=1388&rft.pages=1386-1388&rft.issn=0007-1447&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.1.6124.1386&rft_dat=%3Cjstor_pubme%3E20419162%3C/jstor_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b4256-d32feae2f0d9e2cd738e8b1c7ca59f17578c6f39649b5c2fe173e487010c3e693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1776308592&rft_id=info:pmid/348260&rft_jstor_id=20419162&rfr_iscdi=true